Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.

[1]  I. Jónsdóttir,et al.  Enzyme-Linked Immunosorbent Assay for Quantitation of Human Antibodies to Pneumococcal Polysaccharides , 2003, Clinical Diagnostic Laboratory Immunology.

[2]  Onchee Yu,et al.  Effectiveness of pneumococcal polysaccharide vaccine in older adults. , 2003, The New England journal of medicine.

[3]  A. Schuchat,et al.  Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly. , 2002, Vaccine.

[4]  R. Thompson,et al.  Safety of revaccination with pneumococcal polysaccharide vaccine. , 1999, JAMA.

[5]  M. Leinonen,et al.  Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people , 1998, The Lancet.

[6]  M. Leinonen,et al.  Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. , 1997, The American journal of medicine.

[7]  M. Pichichero,et al.  Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults , 1997, Infection and immunity.

[8]  K. Lottenbach,et al.  Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults. , 1996, The Journal of infectious diseases.

[9]  R. Breiman,et al.  Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. , 1993, JAMA.

[10]  R. Adair,et al.  The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. , 1991, The New England journal of medicine.

[11]  A. Cross,et al.  Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. , 1986, The New England journal of medicine.